Intérêt du béthanéchol chloride dans le traitement de l’hypoactivité détrusorienne chez les patients blessés médullaires. Revue de la littérature et présentation de trois situations

Abrams P, Cardozo L, Fall M, et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–78 Haab F, Amarenco G, Coloby P, et al (2006) Terminologie des troubles fonctionnels du bas appareil urinaire, adaptation française de la terminologie de l’International Continence Society. Pelv Perineol 1:196–206 Even-Schneider A, Denys P, Chartier-Kastler E, Ruffion A (2007) Troubles vésicosphinctériens et traumatismes médullaires Prog Urol 17(3):347–51 Bart S, De Sèze M, Chartier-Kastler E, Ruffion A (2007) Troubles vésicosphinctériens et sclérose en plaques. Prog Urol 17(3):358–64 De Wachter S, Van Meel TD, Wyndaele JJ (2003) Study of the afferent nervous system and its evaluation in women with impaired detrusor contractility treated with bethanechol. Urology 62:54–58 Raibaut P, Terrier A, Jacq C, et al (2008) Intérêt de l’autosondage en cas de rétention urinaire. Prog Urol. 18(3):29–34 De Sèze M (2007) Traitement médicamenteux de l’hypoactivité vésicale. Pelv Perineol 2:184–192 Barendrecht MM, Oelke M, Laguna MP, Michel MC (2007) Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int 99(4):749–52 Krishnamoorthy S, Kekre NS (2009) Detrusor underactivity: To tone or not to tone the bladder? Indian J Urol 25(3):407–8 Wyndaele JJ (2008) Conservative treatment of patients with neurogenic bladder. Eur Urol supplements 7:557–65 Stöhrer M, Blok B, Castro-Diaz D, et al (2009) EAU Guidelines on neurogenic lower urinary tract dysfunction. Eur Urol 56:81–8 Zermann D, Wunderlich H, Derry F, et al (2000) Audit of early management complications after spinal cord injury in firsttreating hospitals. Eur Urol 37(2):156–60 Weld KJ, Dmochowski RR (2000) Effect of bladder management on urological complications in spinal cord injured patients. J Urol 163(3):768–72 Jonas U, Castro-Diaz D, Bemelmans BLH, et al (2003) Neurogenic voiding dysfunctions (NVD). Eur Urol 44(3):I–XV Chancellor MB, Kaufman J (2008) Case for pharmacotherapy development for underactive bladder. Urology 72(5):966–7 King JA, Huddart H, Staff WG (1998) Effect of choline ester analogues, noradrenaline and nifedipine on normal and hypertrophied human urinary bladder detrusor muscle. Gen Pharmacol 30(1):131–6 Khullar V, Cardozo LD (1995) Drugs and the bladder. Curr Obstet Gynaecol 5:110–116 Diokno AC, Lapides J (1977) Action of oral and parenteral bethanechol on decompensated bladder. Urology 10:23–24 Wolfe DL, Ethans K, Hill D, et al (2008) Bladder health and function following spinal cord injury. Spinal Cord Injury Rehabilitation Evidence version 2.0 13:1–119 Fleming AR (1957) The use of urecholine in the prevention of postpartum urinary retention: final report. Am J Obstet Gynecol 74(3):569–71 Kemp B, Kitschke HJ, Goetz M, Heyl W (1997) Prophylaxis and treatment of bladder dysfunction after Wertheim-Meigs operation: the positive effect of early postoperative detrusor stimulation using the cholinergic drug betanecholchloride. Int Urogynecol J Pelvic Floor Dysfunct 8(3):138–41 Barrett DM (1981) The effect of oral bethanechol chloride on voiding in female patients with excessive residual urine: a randomized double-blind study. J Urol 126:640–2 Yamanishi T, Yasuda K, Kamai T, et al (2004) Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol 11:88–96 Gottesman L, Milsom JW, Mazier WP (1989) The use of anxiolytic and parasympathomimetic agents in the treatment of postoperative urinary retention following anorectal surgery. A prospective, randomized, double-blind study. Dis Colon Rectum 32:867–870 Riedl CR, Daha LK, Knoll M, Pflueger H (2002) Bethanechol in the restitution of the acontractile detrusor: a prospective, randomized, double blind, placebo-controlled study. Neurourol Urodyn 21:376 Hindley RG, Brierly RD, Thomas PJ (2004) Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity. BJU Int 93:89–92 Finkbeiner AE (1985) Is bethanechol chloride effective in promoting bladder emptying? A literature review. J Urol 134:443–9